$2.33T
Total marketcap
$84.36B
Total volume
BTC 50.08%     ETH 15.36%
Dominance

Excelsior Biopharma Inc. 6496.TWO Stock

28.2 TWD {{ price }} 0.714288% {{change_pct}}%
COUNTRY
Taiwan
Market Cap
1.33B TWD
LOW - HIGH [24H]
28.1 - 28.25 TWD
VOLUME [24H]
14.54K TWD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.98 TWD

Excelsior Biopharma Inc. Price Chart

Excelsior Biopharma Inc. 6496.TWO Financial and Trading Overview

Excelsior Biopharma Inc. stock price 28.2 TWD
Previous Close 31.3 TWD
Open 31.1 TWD
Bid 31.3 TWD x 0
Ask 31.55 TWD x 0
Day's Range 31.05 - 31.65 TWD
52 Week Range 25.8 - 36.45 TWD
Volume 19.11K TWD
Avg. Volume 64.67K TWD
Market Cap 1.48B TWD
Beta (5Y Monthly) 0.569178
PE Ratio (TTM) N/A
EPS (TTM) -1.98 TWD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date July 13, 2021
1y Target Est N/A

6496.TWO Valuation Measures

Enterprise Value 743.03M TWD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 2.15276
Price/Book (mrq) 1.2519283
Enterprise Value/Revenue 1.083
Enterprise Value/EBITDA -26.867

Trading Information

Excelsior Biopharma Inc. Stock Price History

Beta (5Y Monthly) 0.569178
52-Week Change 11.78%
S&P500 52-Week Change 20.43%
52 Week High 36.45 TWD
52 Week Low 25.8 TWD
50-Day Moving Average 32.23 TWD
200-Day Moving Average 29.35 TWD

6496.TWO Share Statistics

Avg. Volume (3 month) 64.67K TWD
Avg. Daily Volume (10-Days) 36.3K TWD
Shares Outstanding 46.67M
Float N/A
Short Ratio N/A
% Held by Insiders 61.11%
% Held by Institutions 0.33%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -6.92%
Operating Margin (ttm) -5.76%
Gross Margin 40.91%
EBITDA Margin -4.031%

Management Effectiveness

Return on Assets (ttm) -1.45%
Return on Equity (ttm) -3.98%

Income Statement

Revenue (ttm) 686.09M TWD
Revenue Per Share (ttm) 14.96 TWD
Quarterly Revenue Growth (yoy) 8.30%
Gross Profit (ttm) 287.17M TWD
EBITDA -27656000 TWD
Net Income Avi to Common (ttm) -47542000 TWD
Diluted EPS (ttm) -1.01
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.07B TWD
Total Cash Per Share (mrq) 22.85 TWD
Total Debt (mrq) 348.47M TWD
Total Debt/Equity (mrq) 29.53 TWD
Current Ratio (mrq) 3.062
Book Value Per Share (mrq) 25.281

Cash Flow Statement

Operating Cash Flow (ttm) -44089000 TWD
Levered Free Cash Flow (ttm) -39902000 TWD

Profile of Excelsior Biopharma Inc.

Country Taiwan
State N/A
City Taipei
Address No.3, Park Street
ZIP 11503
Phone 886 2 2655 7568
Website https://www.excelsiorgroup.com.tw
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees N/A

Excelsior Biopharma Inc. develops and sells pharmaceutical products in Taiwan, China, and internationally. It offers prescription drugs, over-the-counter drugs, medical devices, healthcare food products, medical supplies, and other products. The company provides its products for the therapeutic areas, such as pediatrics, gastroenterology, neurology, cardiology, dermatology, medical toxicology, dentistry, obstetrics, oncology, hematology, and otorhinolaryngology, as well as infectious diseases. It also offers test kits under the Actim name to detect influenza virus, fecal occult blood, acute pancreatitis, preterm or full-week delivery, and early water breaking. In addition, the company provides toothpaste, and mouth wash and gel products under the Oral7 name; and food and medical beauty maintenance products. Further, it imports and exports active pharmaceutical ingredients; and engages in the research of technologies, and pharmaceutical technologies transfer and cooperative development and improvement activities. The company was formerly known as Excelsior Enterprise Co., Ltd. and changed its name to Excelsior Biopharma Inc. in June 2003. Excelsior Biopharma Inc. was incorporated in 1988 and is headquartered in Taipei, Taiwan.

Q&A For Excelsior Biopharma Inc. Stock

What is a current 6496.TWO stock price?

Excelsior Biopharma Inc. 6496.TWO stock price today per share is 28.2 TWD.

How to purchase Excelsior Biopharma Inc. stock?

You can buy 6496.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Excelsior Biopharma Inc.?

The stock symbol or ticker of Excelsior Biopharma Inc. is 6496.TWO.

Which industry does the Excelsior Biopharma Inc. company belong to?

The Excelsior Biopharma Inc. industry is Drug Manufacturers-Specialty & Generic.

How many shares does Excelsior Biopharma Inc. have in circulation?

The max supply of Excelsior Biopharma Inc. shares is 46.99M.

What is Excelsior Biopharma Inc. Price to Earnings Ratio (PE Ratio)?

Excelsior Biopharma Inc. PE Ratio is now.

What was Excelsior Biopharma Inc. earnings per share over the trailing 12 months (TTM)?

Excelsior Biopharma Inc. EPS is -1.98 TWD over the trailing 12 months.

Which sector does the Excelsior Biopharma Inc. company belong to?

The Excelsior Biopharma Inc. sector is Healthcare.